COMMON STOCK |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Equity [Abstract] | |
| COMMON STOCK | NOTE 5 – COMMON STOCK During the nine months ended September 30, 2026, pursuant to the terms of the Merger with Nika BioTechnology, Inc. (Note 1), the Company issued 7,140,000 shares of common stock of the 204,205,027 shares to be issued, consisting of 1,000,000 shares issued during the three months ended March 31, 2026, 3,140,000 shares issued during the three months ended June 30, 2026, and 3,000,000 shares issued on July 17, 2026.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|